Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2012; 18(42): 6127-6133
Published online Nov 14, 2012. doi: 10.3748/wjg.v18.i42.6127
Published online Nov 14, 2012. doi: 10.3748/wjg.v18.i42.6127
Table 1 Demographics of study patients
| Sertraline | Placebo | P value | |
| Number of patients | 98 | 95 | |
| Age (yr) | 43.0 | 41.6 | 0.515 |
| Sex (male) | 27 | 27 | 1.000 |
| Current smokers (%) | 3.2 | 7.3 | 0.122 |
| Alcohol (%) | 6.2 | 8.3 | 0.295 |
| H. pylori positive (%) | 8.4 | 7.3 | 0.843 |
| NSAID use (%) | 3.1 | 2.6 | 1.000 |
| Predominant symptom n (%) | |||
| Ulcer like | 17 (44.7) | 21 (55.3) | |
| Dysmotility like | 60 (49.2) | 62 (51.8) | |
| Reflux like | 8 (57.1) | 6 (42.9) | |
| Non-specific | 13 (68.4) | 6 (31.6) |
- Citation: Tan VP, Cheung TK, Wong WM, Pang R, Wong BC. Treatment of functional dyspepsia with sertraline: A double-blind randomized placebo-controlled pilot study. World J Gastroenterol 2012; 18(42): 6127-6133
- URL: https://www.wjgnet.com/1007-9327/full/v18/i42/6127.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i42.6127